These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33688863)

  • 1. Metal-phenolic networks for cancer theranostics.
    Liu P; Shi X; Zhong S; Peng Y; Qi Y; Ding J; Zhou W
    Biomater Sci; 2021 Apr; 9(8):2825-2849. PubMed ID: 33688863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Metal-Phenolic Networks for Cancer Theranostics.
    Zhang Z; Xie L; Ju Y; Dai Y
    Small; 2021 Oct; 17(43):e2100314. PubMed ID: 34018690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-phenolic networks: facile assembled complexes for cancer theranostics.
    Xie W; Guo Z; Zhao L; Wei Y
    Theranostics; 2021; 11(13):6407-6426. PubMed ID: 33995665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances of Fe(III)/Fe(II)-MPNs in Biomedical Applications.
    Chen W; Liu M; Yang H; Nezamzadeh-Ejhieh A; Lu C; Pan Y; Liu J; Bai Z
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of metal-phenolic networks in nanomedicine: a review.
    Wang H; Wang D; Yu J; Zhang Y; Zhou Y
    Biomater Sci; 2022 Oct; 10(20):5786-5808. PubMed ID: 36047491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
    Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
    ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
    Chen Q; Liu Z
    Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation.
    Xie L; Li J; Wang L; Dai Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1864. PubMed ID: 36333962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances of copper-based metal phenolic networks in biomedical applications.
    Zhang Y; Hao F; Liu Y; Yang M; Zhang B; Bai Z; Zhao B; Li X
    Colloids Surf B Biointerfaces; 2024 Dec; 244():114163. PubMed ID: 39154599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-Phenolic Networks as Versatile Coating Materials for Biomedical Applications.
    Fan G; Cottet J; Rodriguez-Otero MR; Wasuwanich P; Furst AL
    ACS Appl Bio Mater; 2022 May; ():. PubMed ID: 35535998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
    Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
    Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-Actuated Turn-On Theranostic Nanoplatforms for Imaging-Guided Antibacterial Treatment.
    Yang S; Song Y; Dong H; Hu Y; Jiang J; Chang S; Shao J; Yang D
    Small; 2023 Dec; 19(52):e2304127. PubMed ID: 37649207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
    Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances of redox-responsive nanoplatforms for tumor theranostics.
    Chen M; Liu D; Liu F; Wu Y; Peng X; Song F
    J Control Release; 2021 Apr; 332():269-284. PubMed ID: 33662455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic nanoparticles: a novel platform for cancer theranostics.
    Singh A; Sahoo SK
    Drug Discov Today; 2014 Apr; 19(4):474-81. PubMed ID: 24140592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Perspective in Cancer Theranostics Based on Gold Nanoparticles.
    Chatterjee S; Liang F
    Anticancer Agents Med Chem; 2022; 22(13):2354-2357. PubMed ID: 35196973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
    Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
    Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalable fabrication of metal-phenolic nanoparticles by coordination-driven flash nanocomplexation for cancer theranostics.
    Liu Z; Le Z; Lu L; Zhu Y; Yang C; Zhao P; Wang Z; Shen J; Liu L; Chen Y
    Nanoscale; 2019 May; 11(19):9410-9421. PubMed ID: 31038500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.